Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enovis Corporation stock logo
ENOV
Enovis
$31.80
+0.7%
$29.85
$25.47
$49.83
$1.82B1.681.18 million shs1.17 million shs
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
$28.61
+1.1%
$10.38
$8.94
$11.70
$527.92M0.08102,067 shs12,076 shs
Progyny, Inc. stock logo
PGNY
Progyny
$22.51
-2.8%
$23.03
$13.39
$26.76
$1.94B1.331.37 million shs801,637 shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$18.57
-1.1%
$20.26
$16.60
$28.47
$1.37B1.791.15 million shs688,777 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enovis Corporation stock logo
ENOV
Enovis
+3.57%+0.18%+9.94%-0.85%-26.71%
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
+0.27%+1.43%+3.18%+7.59%+16,751.07%
Progyny, Inc. stock logo
PGNY
Progyny
+2.39%-1.66%+6.38%+10.18%+1.18%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
+3.47%-1.00%-0.37%-12.37%-8.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enovis Corporation stock logo
ENOV
Enovis
$31.80
+0.7%
$29.85
$25.47
$49.83
$1.82B1.681.18 million shs1.17 million shs
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
$28.61
+1.1%
$10.38
$8.94
$11.70
$527.92M0.08102,067 shs12,076 shs
Progyny, Inc. stock logo
PGNY
Progyny
$22.51
-2.8%
$23.03
$13.39
$26.76
$1.94B1.331.37 million shs801,637 shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$18.57
-1.1%
$20.26
$16.60
$28.47
$1.37B1.791.15 million shs688,777 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enovis Corporation stock logo
ENOV
Enovis
+3.57%+0.18%+9.94%-0.85%-26.71%
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
+0.27%+1.43%+3.18%+7.59%+16,751.07%
Progyny, Inc. stock logo
PGNY
Progyny
+2.39%-1.66%+6.38%+10.18%+1.18%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
+3.47%-1.00%-0.37%-12.37%-8.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enovis Corporation stock logo
ENOV
Enovis
3.00
Buy$51.0060.38% Upside
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
0.00
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
2.73
Moderate Buy$25.3012.39% Upside
Schrodinger, Inc. stock logo
SDGR
Schrodinger
2.67
Moderate Buy$27.8349.88% Upside

Current Analyst Ratings Breakdown

Latest LCAP, PGNY, SDGR, and ENOV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2025
Progyny, Inc. stock logo
PGNY
Progyny
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$23.00 ➝ $25.00
8/20/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$21.00 ➝ $23.00
8/18/2025
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$28.00 ➝ $19.00
8/15/2025
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyNeutral$35.00 ➝ $20.00
8/14/2025
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$25.00
8/14/2025
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$25.00
8/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$28.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$70.00 ➝ $58.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$65.00 ➝ $57.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$48.00 ➝ $41.00
8/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$26.00 ➝ $28.00
(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.86$20.13 per share1.58$45.10 per share0.71
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
N/AN/A$1.39 per share20.64($2.85) per shareN/A
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.66$0.34 per share65.58$4.96 per share4.54
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$207.54M6.59N/AN/A$5.78 per share3.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$14.25N/A9.97N/A-37.80%6.78%3.73%11/5/2025 (Estimated)
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
$3.21MN/A0.00N/AN/A-44.30%1.39%N/A
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5938.1534.631.854.28%10.69%7.12%11/11/2025 (Estimated)
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$187.12M-$2.48N/AN/AN/A-76.22%-45.70%-24.81%11/11/2025 (Estimated)

Latest LCAP, PGNY, SDGR, and ENOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.79+$0.05-$0.64$555.80 million$564.50 million
8/7/2025Q2 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.42$0.19-$0.23$0.19$315.70 million$332.87 million
8/6/2025Q2 2025
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$0.83-$0.59+$0.24-$0.59$52.03 million$54.76 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enovis Corporation stock logo
ENOV
Enovis
0.53
2.25
1.15
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
N/A
0.05
0.05
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.70
2.70
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/A
3.30
3.30

Institutional Ownership

CompanyInstitutional Ownership
Enovis Corporation stock logo
ENOV
Enovis
98.45%
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
79.05%

Insider Ownership

CompanyInsider Ownership
Enovis Corporation stock logo
ENOV
Enovis
2.70%
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
19.40%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
21.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.16 million55.62 millionOptionable
Lionheart Acquisition Co. II stock logo
LCAP
Lionheart Acquisition Co. II
318.45 million14.87 millionNot Optionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.98 million77.90 millionOptionable
Schrodinger, Inc. stock logo
SDGR
Schrodinger
79073.61 million58.15 millionOptionable

Recent News About These Companies

Schrödinger: A Complex Story With Many Moving Parts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Enovis stock logo

Enovis NYSE:ENOV

$31.80 +0.22 (+0.70%)
Closing price 03:59 PM Eastern
Extended Trading
$32.25 +0.45 (+1.42%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Lionheart Acquisition Co. II stock logo

Lionheart Acquisition Co. II NASDAQ:LCAP

Lionheart Acquisition Corporation II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in PropTech sector. The company was incorporated in 2019 and is based in Miami, Florida.

Progyny stock logo

Progyny NASDAQ:PGNY

$22.51 -0.66 (-2.85%)
Closing price 04:00 PM Eastern
Extended Trading
$22.52 +0.00 (+0.02%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Schrodinger stock logo

Schrodinger NASDAQ:SDGR

$18.57 -0.21 (-1.12%)
Closing price 04:00 PM Eastern
Extended Trading
$18.71 +0.14 (+0.75%)
As of 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.